POCI
PRECISION OPTICS CORPORATION, INC.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$4.27
−1.16%Year over year
Reported trailing growth
- Revenue
- +65.2%
- EBITDA
- +39.5%
- EBIT
- +36.8%
- EPS
- +46.7%
- Free cash flow
- +47.7%
- Operating cash flow
- +56.3%
Forward estimates
Based on analyst estimates
- Revenue
- -20.4%
- EBITDA
- +64.6%
- EPS
- +63.3%
Three-year CAGR
- Revenue
- +14.4%
- EBITDA
- +40.1%
- EBIT
- +36.8%
- Net income
- +37.2%
- EPS
- +49.4%
- Free cash flow
- +47.6%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026